STM publisher Elsevier has announced the publication of Drug Discovery Approaches for the Treatment of Neurodegenerative Disorders: Alzheimer's Disease, edited by Adeboye Adejare. The book aims to improve drug discovery and development for neurodegenerative disorders by focusing on current knowledge and strategies in Alzheimer's disease (AD). Also in recognition of Alzheimer's Disease Awareness and Caregivers Month, Elsevier has published five additional titles on Alzheimer's and other neurological diseases, with a sixth slated for publication in March 2017.
Exploring diagnosis, epidemiology, drug discovery strategies, current therapeutics, and much more, Drug Discovery Approaches for the Treatment of Neurodegenerative Disorders: Alzheimer's Disease is projected as a valuable resource for all pharmaceutical scientists, pharmacologists, neuroscientists and clinical researchers working in this area. The book illustrates why some drugs tend to fail at the clinical stage, and examines AD within the overall context of improving the drug discovery process for the treatment of other neurodegenerative disorders.
The seven new neurological diseases titles are: Drug Discovery Approaches for the Treatment of Neurodegenerative Disorders: Alzheimer's Disease edited by Adeboye Adejare; Intracellular Consequences of Amyloid in Alzheimer's Disease by Michael R. D'Andrea; Trace Amines and Neurological Disorders: Potential Mechanisms and Risk Factors edited by Tahira Farooqui and Akhlaq A. Farooqui; Biomarkers in Alzheimer's Disease by Tapan Kumar Khan; The Cerebral Cortex in Neurodegenerative and Neuropsychiatric Disorders: Experimental Approaches to Clinical Issues edited by David Cechetto and Nina Weishaupt; Functional Neurologic Disorders edited by Mark Hallett, Jon Stone and Alan Carson; and Neuroprotection in Alzheimer's Disease edited by Illana Gozes (coming in March 2017).
In order to meet content needs in the neurological sciences, Elsevier uses proprietary tools to identify the gaps in coverage of the topics. Editorial teams strategically fill those gaps with content written by key influencers in the field, giving students, faculty and researchers the content they need to answer challenging questions and improve outcomes. These new books, which will educate the next generation of neurologists and AD researchers, and provide critical foundational content for information professionals, are key examples of how Elsevier is enabling science to drive innovation.
Brought to you by Scope e-Knowledge Center, a world-leading provider of metadata services, abstraction, indexing, entity extraction and knowledge organisation models (Taxonomies, Thesauri and Ontologies).
